Colorectal cancer

New pharmacologic strategies for prevention and treatment

Paul M Dainer, C. R. DiPiro, C. S. Richards

Research output: Contribution to journalReview article

Abstract

Despite technological advances allowing for earlier detection of colorectal cancer and more effective treatment options, approximately 57,000 people will die from colorectal cancer in 1993. Prospective studies have shown positive correlations between high-fat, low-fiber diets and colorectal adenomas and carcinomas. Dietary intervention appears to have potential as a preventive measure; however, cultural and behavioral eating habits may prove difficult to overcome. Prostaglandin and ornithine decarboxylase inhibitors show promise as chemopreventive agents. Leucovorin, levamisole, interferon, and N-(phosphonacetyl)-1-aspartic acid (PALA) modulation of 5-fluorouracil (5-FU) continues to be studied for the treatment of metastatic disease. Adjuvant therapy represents the area of greatest gain in the medical treatment of colon cancer.

Original languageEnglish (US)
Pages (from-to)354-360+363
JournalHospital Formulary
Volume28
Issue number4
StatePublished - Jan 1 1993

Fingerprint

Colorectal Neoplasms
Levamisole
Fat-Restricted Diet
Leucovorin
Feeding Behavior
Therapeutics
Early Detection of Cancer
Aspartic Acid
Fluorouracil
Adenoma
Colonic Neoplasms
Interferons
Prostaglandins
Prospective Studies

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Colorectal cancer : New pharmacologic strategies for prevention and treatment. / Dainer, Paul M; DiPiro, C. R.; Richards, C. S.

In: Hospital Formulary, Vol. 28, No. 4, 01.01.1993, p. 354-360+363.

Research output: Contribution to journalReview article

Dainer, PM, DiPiro, CR & Richards, CS 1993, 'Colorectal cancer: New pharmacologic strategies for prevention and treatment', Hospital Formulary, vol. 28, no. 4, pp. 354-360+363.
Dainer, Paul M ; DiPiro, C. R. ; Richards, C. S. / Colorectal cancer : New pharmacologic strategies for prevention and treatment. In: Hospital Formulary. 1993 ; Vol. 28, No. 4. pp. 354-360+363.
@article{113d978159e142aeb740cbe42aae2f0b,
title = "Colorectal cancer: New pharmacologic strategies for prevention and treatment",
abstract = "Despite technological advances allowing for earlier detection of colorectal cancer and more effective treatment options, approximately 57,000 people will die from colorectal cancer in 1993. Prospective studies have shown positive correlations between high-fat, low-fiber diets and colorectal adenomas and carcinomas. Dietary intervention appears to have potential as a preventive measure; however, cultural and behavioral eating habits may prove difficult to overcome. Prostaglandin and ornithine decarboxylase inhibitors show promise as chemopreventive agents. Leucovorin, levamisole, interferon, and N-(phosphonacetyl)-1-aspartic acid (PALA) modulation of 5-fluorouracil (5-FU) continues to be studied for the treatment of metastatic disease. Adjuvant therapy represents the area of greatest gain in the medical treatment of colon cancer.",
author = "Dainer, {Paul M} and DiPiro, {C. R.} and Richards, {C. S.}",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "28",
pages = "354--360+363",
journal = "Hospital Formulary",
issn = "0098-6909",
publisher = "Advanstar Communications",
number = "4",

}

TY - JOUR

T1 - Colorectal cancer

T2 - New pharmacologic strategies for prevention and treatment

AU - Dainer, Paul M

AU - DiPiro, C. R.

AU - Richards, C. S.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Despite technological advances allowing for earlier detection of colorectal cancer and more effective treatment options, approximately 57,000 people will die from colorectal cancer in 1993. Prospective studies have shown positive correlations between high-fat, low-fiber diets and colorectal adenomas and carcinomas. Dietary intervention appears to have potential as a preventive measure; however, cultural and behavioral eating habits may prove difficult to overcome. Prostaglandin and ornithine decarboxylase inhibitors show promise as chemopreventive agents. Leucovorin, levamisole, interferon, and N-(phosphonacetyl)-1-aspartic acid (PALA) modulation of 5-fluorouracil (5-FU) continues to be studied for the treatment of metastatic disease. Adjuvant therapy represents the area of greatest gain in the medical treatment of colon cancer.

AB - Despite technological advances allowing for earlier detection of colorectal cancer and more effective treatment options, approximately 57,000 people will die from colorectal cancer in 1993. Prospective studies have shown positive correlations between high-fat, low-fiber diets and colorectal adenomas and carcinomas. Dietary intervention appears to have potential as a preventive measure; however, cultural and behavioral eating habits may prove difficult to overcome. Prostaglandin and ornithine decarboxylase inhibitors show promise as chemopreventive agents. Leucovorin, levamisole, interferon, and N-(phosphonacetyl)-1-aspartic acid (PALA) modulation of 5-fluorouracil (5-FU) continues to be studied for the treatment of metastatic disease. Adjuvant therapy represents the area of greatest gain in the medical treatment of colon cancer.

UR - http://www.scopus.com/inward/record.url?scp=0027273975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027273975&partnerID=8YFLogxK

M3 - Review article

VL - 28

SP - 354-360+363

JO - Hospital Formulary

JF - Hospital Formulary

SN - 0098-6909

IS - 4

ER -